Differences in mortality profile of tuberculosis patients related to tuberculosis-Aids co-morbidity;Perfil de mortalidade de pacientes com tuberculose relacionada à comorbidade tuberculose-Aids

Revista de Saude Publica

Volumn 38, Issue 4, 2004, Pages 503-510

  Bosco de Oliveira, Helenice ^a,b   Marín León, Leticia ^a   Corrêa Cardoso, Janaina ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Unicamp ^*  (Brazil)

Author keywords

AIDS related opportunistic infections; Tuberculosis AIDS, co morbidity; Underlying cause of death

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; BACTERIUM CULTURE; BRAZIL; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRAPULMONARY TUBERCULOSIS; FATALITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; REGISTER; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 4544325798     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102004000400004     Document Type: Article

References (18)

1. Antunes JLF, Waldman EA. Tuberculosis in the twentieth century: time-series mortality in São Paulo, Brazil, 1900-97. Cad Saúde Pública 1999;15:463-76.
2. Barr RG, Diez-Roux AV, Knirsch CA. Neighborhood poverty and the resurgence of tuberculosis in New York City, 1984-1992. Am J Public Health 2001;91:1487-93.
3. Boerma JT, Nunn AJ, Whitworth JA. Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries. AIDS 1998;12 (Suppl 1):S3-14.
4. Braun MM, Cote TR, Rabkin CS. Trends in death with tuberculosis during AIDS era. JAMA 1993;269:2865-8.
5. Davies PD. Tuberculosis in the elderly. Epidemiology and optimal management. Drugs Aging 1996;8:436-44.
6. Deriemer K, Rudoy I, Schecter GF, Hopewell PC, Daley CL. The epidemiology of tuberculosis diagnosed after death in San Francisco, 1986-1995. Int J Tuberc Lung Dis 1999;3:488-93.
7. Franco J, Blanquer R. Mortality from tuberculosis in Spain from 1970 to 1993: changes in epidemiology trends during the acquired immune-deficiency syndrome epidemic. Int J Tuberc Lung Dis 1998;2:663-96.
8. Gledovic Z, Jovanovic M, Pekmezovic T. Tuberculosis trends in Central Serbia in the period 1956-1996. Int J Tuberc Lung Dis 2000;4:32-5.
9. Leung CC, Yew WW, Chan CK, Chau CH, Tam CM, Lato CW et al. Tuberculosis in older people: a retrospective and comparative study from Hong Kong. J Am Geratr Soc 2002;50:1219-26.
10. a ed. Rio de Janeiro; 2002, p. 236.
11. Oliveira HB, Moreira Filho DC. Abandono de tratamento e recidiva da tuberculose: aspectos de episódios prévios, Campinas, SP, Brasil, 1993-1994. Rev Saúde Pública 2000; 34:437-43.
12. Pablos-Méndez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 1996;276:1223-8.
13. Rajagopalan S. Tuberculosis and aging: a global health problem. Clin Infect Dis 2001:33:1034-9.
14. Ruffino-Netto A. Tuberculose: a calamidade negligenciada. Rev Soc Bras Med Trop 2002;35:51-8.
15. Sacks LV, Pendle S. Factors related to in-hospital deaths in patients with tuberculosis. Arch Intern Med 1998;158:1916-22.
16. Tollman SM, Kahn K, Garenne M, Gear JSS. Reversal in mortality trends: evidence from the agincourt field site, South Africa, 1992-1995. AIDS 1999;13:1091-7.
17. Zafran N, Heldal E, Pavlovic S, Vuckovic D, Boe J. Why do our patients die of active tuberculosis in the era of effective therapy? Tuberc Lung Dis 1994;75:329-33.
18. Zellweger JP, Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 1998;2:372-7.